Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mick Radio-Nuclear Instruments is a premier provider of brachytherapy accessories and applicators, specializing in high-precision instruments for radiation oncology. The company is widely recognized for the Mick Applicator, which serves as the industry standard for manual seed implantation in prostate brachytherapy. Their extensive product portfolio includes specialized needles, templates, and applicators designed for the treatment of various malignancies, including gynecological and breast cancers. Acquired by Elekta in 2013, the company continues to operate as a key component of Elekta's brachytherapy division, providing clinicians with essential tools for targeted internal radiation therapy. Their products are utilized globally to improve the accuracy and delivery of radioactive sources in oncological procedures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mick Radio-Nuclear Instruments.